Incorporation of tumor vasculature targeting motifs into moloney murine leukemia virus Env escort proteins enhances retrovirus binding and transduction of human endothelial cells

Citation
Lq. Liu et al., Incorporation of tumor vasculature targeting motifs into moloney murine leukemia virus Env escort proteins enhances retrovirus binding and transduction of human endothelial cells, J VIROLOGY, 74(11), 2000, pp. 5320-5328
Citations number
64
Categorie Soggetti
Microbiology
Journal title
JOURNAL OF VIROLOGY
ISSN journal
0022538X → ACNP
Volume
74
Issue
11
Year of publication
2000
Pages
5320 - 5328
Database
ISI
SICI code
0022-538X(200006)74:11<5320:IOTVTM>2.0.ZU;2-7
Abstract
Adhesion receptors expressed on the surfaces of tumor-activated endothelial cells provide an advantageous locus for targeting gene therapy vectors to angiogenic tissues and/or tumor vasculature. In this study, we engineered a series of Bsn-Gly-Arg (NGR)-containing congeners of the presumptive cell b inding motif contained within the ninth type III repeat of fibronectin and displayed these tumor vasculature targeting motifs (TVTMs) within the conte xt of Moloney murine leukemia envelope "escort" proteins. Comparative studi es of envelope incorporation into viral particles and evaluation of the cel l binding properties of the targeted vectors revealed critical structural f eatures, thus identifying a subset of optimal TVTMs. Utilizing a modified E LISA. to evaluate viral binding to target cells, we observed a significant down-regulation of TVTM-virion binding to human endothelial cells following sustained (48-h) exposure to VEGF. Normalized for equivalent titers (10(6) CFU/ml), as assayed on NIH 3T3 cells, vectors displaying TVTM escort prote ins significantly enhanced the transduction efficiency from 12.2 to 37.4% i n human KSY-1 endothelial cell cultures (P < 0.001) and from 0.4 to 4.1% in human umbilical vein endothelial cell (HUVEC) cultures (P < 0.001). In sum mary, these studies utilized an engineering approach to identify a subset o f TVTMs that are stably incorporated as envelope ''escort" proteins into re troviral vectors and that, by functioning to improve the binding efficiency and transduction of both HUVEC and KSY1 endothelial cells, may have therap eutic potential for targeting gene delivery to the tumor-associated vascula ture,